converting between glp-1 agonists Metabolic Flux Adaptations During Receptor Agonist Therapy: Redox Implications | Current Obesity Reports What is GLP-1 and Its
Description
Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update
DOI: 10.1038/s41574-020-00411-y
All authors have reviewed the submitted version and agreed to publish the manuscript
A number of prospective randomised controlled trials are ongoing, to examine whether GLP-1 drugs can reduce the risk of dementia.
Benjamin Bert, MD , a board-certified ophthalmologist at MemorialCare Orange Coast Medical Center in Fountain Valley, California, added that as GLP-1s help with controlling blood sugar, their use may also lead to changes in vision prescription
